对“高表达碳水化合物硫转移酶11与肝细胞癌不良预后和免疫逃避相关”的更正

IF 3.1 2区医学 Q2 ONCOLOGY

Cancer Medicine Pub Date : 2025-05-01 DOI:10.1002/cam4.70918

引用次数: 0

摘要

熊德东，李建东，何瑞强，李明明，潘玉青，何晓玲，党义伟，陈刚。糖基磺酸转移酶11高表达与肝癌预后不良及免疫逃避相关。癌症医学[j]; 2009; 12:4938-4950。https://doi.org/10.1002/cam4.5186In“致谢”部分，资助号“NSFC82160862”错误。正确的资助号为“NSFC82160762”。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to “Highly Expressed Carbohydrate Sulfotransferase 11 Correlates With Unfavorable Prognosis and Immune Evasion of Hepatocellular Carcinoma”

Xiong DD, Li JD, He RQ, Li MX, Pan YQ, He XL, Dang YW, Chen G. Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma. Cancer Med. 2023;12:4938–4950. https://doi.org/10.1002/cam4.5186

In the “ACKNOWLEDGEMENTS” section, the grant number “NSFC82160862” was incorrect. The correct grant number is “NSFC82160762”.

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Medicine ONCOLOGY-

CiteScore

5.50

自引率

2.50%

发文量

907

审稿时长

19 weeks

期刊介绍： Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.